USPTO serial 97436296
MEDLY
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- RIOS, SASHA BOSHART
- Law office
- TMO LAW OFFICE 125
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with MEDLY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Felicia J. Boyd
Felicia J. Boyd NORTON ROSE FULBRIGHT US LLP60 SOUTH SIXTH STREET, SUITE 3100MINNEAPOLIS, MN 55402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable mobile applications for use in self-management of chronic medical conditions, in particular heart failure, chronic obstructive pulmonary disease, asthma, diabetes, hypertension, cancer, pain management, and mental health; downloadable software applications for mobile devices, in particular mobile phones and computers, for monitoring and managing patient medical information; downloadable computer software for controlling and managing patient medical information; downloadable mobile applications for use in chronic medical condition research and analysis for scientific purposes; downloadable mobile applications for use in the diagnosis and treatment of chronic medical conditions, namely, cardiovascular, metabolic, respiratory, and mental health conditions; downloadable mobile applications for use in cardiovascular, metabolic, respiratory, and mental health examination and assessment for medical diagnostic purposes; Downloadable mobile applications for recording and tracking physiological and patient reported indicators; downloadable computer software featuring algorithms used to analyze mental health; downloadable mobile applications for recording and tracking physiological and patient reported indicators, generating patient self-care messages based on treatment plans, and alerting clinicians on the patient's care team when algorithms indicate action is needed; downloadable mobile applications for use in management and treatment of chronic medical conditions, namely, cancer and pain management analysis for medical and diagnostic and treatment purposes; downloadable mobile applications for use in cancer and pain management examination and assessment for medical diagnostic purposes | ACTIVE | — |
| 010 | Electronic blood pressure monitors; heart monitors; heart rate monitors; blood glucose monitors being medical apparatus for monitoring blood glucose levels; blood pressure monitors; diabetes monitoring equipment for sampling and analyzing blood and body tissue being medical test kits for diabetes monitoring for home use | ACTIVE | — |
| 042 | Basic clinical research in the field of medicine, namely, conducting clinical trials for others; basic clinical research in the field of medicine, namely, clinical research in the field of chronic conditions, namely, cardiovascular conditions, metabolic conditions, respiratory conditions, mental health conditions, and cancer and clinical research in the fields of radiology, chemotherapy, coronary artery bypass surgery; software as a service (SaaS) services featuring software for managing chronic conditions, namely, cardiovascular, metabolic, respiratory and mental health diagnosis and treatment; software as a service (SaaS) services for managing chronic disease; platform as a service (PaaS) featuring computer software platforms for use by healthcare professionals for use in cardiovascular, metabolic, respiratory, and mental health condition diagnosis and treatment; platform as a service (PaaS) featuring computer software platforms for use in chronic disease management; computer software technical support services, namely, troubleshooting in the nature of diagnosing computer software problems; design, development and implementation of software; computer software development in the field of mobile applications; computer software installation and maintenance; computer software system design; maintenance and updating of computer software; providing temporary use of non-downloadable computer software for connecting doctors with medical patients and providing medical information to doctors; technical support in the nature of troubleshooting to diagnose computer hardware and software problems; Web based chronic condition research and analysis services for scientific purposes being medical research services; providing temporary use of non-downloadable computer software for recording and tracking physiological and patient reported indicators; software as a service (SaaS) services featuring software for use in management of chronic conditions, namely, for cancer diagnosis and treatment and pain management; platform as a service (PaaS) featuring computer software platforms for use by healthcare professionals for use in the diagnosis and treatment of cancer and for use in pain management | ACTIVE | — |
| 044 | Web-based chronic disease analysis services for medical and diagnostic and treatment purposes, namely, cardiovascular, metabolic, respiratory, and mental health analysis services for medical and diagnostic and treatment purposes; web-based cardiovascular, metabolic, respiratory, and mental health examination and assessment for medical diagnostic purposes; mental health services; hospital services; telemedicine services; medical clinic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; dietary and nutritional guidance; medical services in the field of diabetes; home health care services; managed health care services; providing emergency health information by telephone; Web-based chronic disease analysis services for medical and diagnostic and treatment purposes, namely, cancer and pain management analysis services for medical and diagnostic and treatment purposes; web-based cancer and pain management examination and assessment for medical diagnostic purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VITALL INTELLIGENCE INC.
- Other trademarks owned by University Health Network
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MEDLY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 19, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 19, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 10, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 19, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 19, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 19, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 13, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 14, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 14, 2026 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 14, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Nov 17, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 16, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 16, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 16, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2025 | ALIE | ASSIGNED TO LIE | — |
| Apr 30, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 13, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 13, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 13, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 31, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 12, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 11, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 11, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 11, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 19, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 5, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jun 5, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Mar 17, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2022 | NWAP | NEW APPLICATION ENTERED | — |